Daily Archives: January 25, 2017

0

Cambridge Cognition receives FDA approval for memory impairment test

Digital health company Cambridge Cognition has received regulatory clearance from the FDA to market its memory impairment device as a medical device. Cambridge Cognition’s Cantab Mobile product, is a cognitive assessment designed to detect clinically-relevant memory impairment. The app uses a touchscreen test to help detect symptoms of depression and alzheimer’s. The test uses visuospatial…

© 2019 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.

Privacy policy

Terms and conditions